NASDAQ: PYXS
Pyxis Oncology Inc Stock Ownership - Who owns Pyxis Oncology?

Insider buying vs selling

Have Pyxis Oncology Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jakob DupontDirector2026-06-3035,000$1.60
$56.00kBuy
Jakob DupontDirector2026-06-3035,000$3.06
$107.10kSell

1 of 1

PYXS insiders have bought as... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PYXS insiders and whales buy or sell their stock.

PYXS Shareholders

What type of owners hold Pyxis Oncology Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Gordonmd Global Investments LP12.02%10,024,909$32.18MInsider
Pfizer Inc8.43%7,032,770$22.58MInsider
Barclays PLC4.17%3,477,975$11.16MInsider
Pamela Ann Connealy4.11%3,425,179$10.99MInsider
Bayer World Investments Bv3.29%2,742,338$8.80MInsider
Lara Sullivan2.88%2,403,882$7.72MInsider
Cormorant Asset Management LP1.34%1,118,854$3.59MInsider
Jay Feingold0.88%730,345$2.34MInsider
Connealy Pamela Yanchik0.71%594,313$1.91MInsider
Jitendra Wadhane0.61%512,882$1.65MInsider

1 of 3

PYXS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PYXS0.04%40.13%Net BuyingNet Buying
ALXO0.08%10.66%Net BuyingNet Selling
CAMP0.07%49.92%Net SellingNet Selling
BCYC0.05%43.51%Net SellingNet Selling
TRDA0.06%99.94%Net SellingNet Selling

Pyxis Oncology Stock Ownership FAQ

Who owns Pyxis Oncology?

Pyxis Oncology (NASDAQ: PYXS) is owned by 0.04% institutional shareholders, 40.13% Pyxis Oncology insiders, and 59.83% retail investors. Gordonmd Global Investments LP is the largest individual Pyxis Oncology shareholder, owning 10.02M shares representing 12.02% of the company. Gordonmd Global Investments LP's Pyxis Oncology shares are currently valued at $32.18M.

If you're new to stock investing, here's how to buy Pyxis Oncology stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.